002693 *ST双成
已收盘 12-12 15:00:00
资讯
新帖
简况
*ST双成：主营业务涵盖药品研发生产销售
证券之星 · 12-09
*ST双成：主营业务涵盖药品研发生产销售
*ST双成：公司是否触及退市风险警示需经2025年度审计判断
证券之星 · 12-09
*ST双成：公司是否触及退市风险警示需经2025年度审计判断
*ST双成（002693）公司公告终止实施2025年限制性股票与股票期权激励计划，12月05日股价下跌1.84%
证券之星 · 12-05
*ST双成（002693）公司公告终止实施2025年限制性股票与股票期权激励计划，12月05日股价下跌1.84%
*ST双成：销售模式为招商与市场推广结合
证券之星 · 11-26
*ST双成：销售模式为招商与市场推广结合
异动快报：*ST双成（002693）11月19日13点3分触及跌停板
证券之星 · 11-19
异动快报：*ST双成（002693）11月19日13点3分触及跌停板
*ST双成（002693）披露终止实施2025年限制性股票与股票期权激励计划，11月18日股价上涨4.96%
证券之星 · 11-18
*ST双成（002693）披露终止实施2025年限制性股票与股票期权激励计划，11月18日股价上涨4.96%
异动快报：*ST双成（002693）11月18日9点35分触及涨停板
证券之星 · 11-18
异动快报：*ST双成（002693）11月18日9点35分触及涨停板
*ST双成：企业所得税已享受15%税率
证券之星 · 11-07
*ST双成：企业所得税已享受15%税率
*ST双成(002693)9月30日股东户数4.42万户，较上期减少19.43%
证券之星 · 10-30
*ST双成(002693)9月30日股东户数4.42万户，较上期减少19.43%
*ST双成：公司没有该专利
证券之星 · 10-30
*ST双成：公司没有该专利
*ST双成：不存在提前泄露3季度业绩的情况
证券之星 · 10-30
*ST双成：不存在提前泄露3季度业绩的情况
股市必读：*ST双成（002693）10月29日董秘有最新回复
证券之星 · 10-30
股市必读：*ST双成（002693）10月29日董秘有最新回复
图解*ST双成三季报：第三季度单季净利润同比增长176.31%
证券之星 · 10-30
图解*ST双成三季报：第三季度单季净利润同比增长176.31%
股市必读：*ST双成（002693）10月28日董秘有最新回复
证券之星 · 10-29
股市必读：*ST双成（002693）10月28日董秘有最新回复
*ST双成：公司各位高管均正常履职
证券之星 · 10-28
*ST双成：公司各位高管均正常履职
股市必读：*ST双成（002693）10月23日董秘有最新回复
证券之星 · 10-24
股市必读：*ST双成（002693）10月23日董秘有最新回复
股市必读：*ST双成（002693）10月21日董秘有最新回复
证券之星 · 10-22
股市必读：*ST双成（002693）10月21日董秘有最新回复
*ST双成：未接到实控人及大股东减持计划通知
证券之星 · 10-21
*ST双成：未接到实控人及大股东减持计划通知
*ST双成：股票收盘价连续二十个交易日低于1元将被终止上市
证券之星 · 10-20
*ST双成：股票收盘价连续二十个交易日低于1元将被终止上市
*ST双成：于晓风女士为公司董事会秘书
证券之星 · 10-20
*ST双成：于晓风女士为公司董事会秘书
暂无数据
公司概况
公司名称：
海南双成药业股份有限公司
所属行业：
医药制造业
上市日期：
2012-08-08
主营业务：
海南双成药业股份有限公司的主营业务是药品注射剂、固体制剂、原料药的研发、生产、销售。公司的主要产品是注射用生长抑素、注射用比伐芦定、依替巴肽注射液、醋酸奥曲肽注射液、注射用紫杉醇(白蛋白结合型)。公司曾荣获国家知识产权示范企业、优势企业奖励。
发行价格：
20.00
{"stockData":{"symbol":"002693","market":"SZ","secType":"STK","nameCN":"*ST双成","latestPrice":6.88,"timestamp":1765523031000,"preClose":6.95,"halted":0,"volume":5568900,"delay":0,"changeRate":-0.0101,"floatShares":411000000,"shares":415000000,"eps":-0.1037,"marketStatus":"已收盘","change":-0.07,"latestTime":"12-12 15:00:00","open":6.9,"high":6.93,"low":6.81,"amount":38268500,"amplitude":0.0173,"askPrice":6.89,"askSize":257,"bidPrice":6.88,"bidSize":185,"shortable":0,"etf":0,"ttmEps":-0.1037,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765762200000},"marketStatusCode":5,"adr":0,"adjPreClose":6.95,"symbolType":"stock","openAndCloseTimeList":[[1765503000000,1765510200000],[1765515600000,1765522800000]],"highLimit":7.3,"lowLimit":6.6,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":414689750,"isCdr":false,"pbRate":7.37,"roa":"--","roe":"--","epsLYR":-0.19,"committee":0.433657,"marketValue":2853000000,"turnoverRate":0.0136,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2025-12-15。","floatMarketCap":2828000000},"requestUrl":"/m/hq/s/002693/tweets","defaultTab":"tweets","newsList":[{"id":"2590134629","title":"*ST双成：主营业务涵盖药品研发生产销售","url":"https://stock-news.laohu8.com/highlight/detail?id=2590134629","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590134629?lang=zh_cn&edition=full","pubTime":"2025-12-09 20:51","pubTimestamp":1765284693,"startTime":"0","endTime":"0","summary":"证券之星消息，*ST双成(002693)12月08日在投资者关系平台上答复投资者关心的问题。投资者提问：贵公司是否考虑过向不同领域开展业务？*ST双成回复：尊敬的投资者您好，公司所属行业为医药制造业，公司主营业务涵盖药品注射剂、固体制剂、原料药的研发、生产、销售等，感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120900037434.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"gpt_icon":0},{"id":"2590346406","title":"*ST双成：公司是否触及退市风险警示需经2025年度审计判断","url":"https://stock-news.laohu8.com/highlight/detail?id=2590346406","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590346406?lang=zh_cn&edition=full","pubTime":"2025-12-09 20:51","pubTimestamp":1765284686,"startTime":"0","endTime":"0","summary":"证券之星消息，*ST双成12月08日在投资者关系平台上答复投资者关心的问题。投资者提问：若*ST双成2025年全年净利润为正但营收不足3亿，能否成功保壳并撤销退市风险警示（摘帽）？*ST双成回复：尊敬的投资者您好。公司是否触及上述条款需经2025年度会计师审计的年度报告进行判断，公司将严格按照股票上市规则的相关规定，认真履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120900037426.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"gpt_icon":0},{"id":"2589093818","title":"*ST双成（002693）公司公告终止实施2025年限制性股票与股票期权激励计划，12月05日股价下跌1.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589093818","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589093818?lang=zh_cn&edition=full","pubTime":"2025-12-05 22:23","pubTimestamp":1764944609,"startTime":"0","endTime":"0","summary":"截至2025年12月5日收盘，*ST双成报收于6.93元，较前一交易日下跌1.84%，最新总市值为28.74亿元。近日，海南双成药业股份有限公司召开2025年第三次临时股东会，审议通过了《关于终止实施2025年限制性股票与股票期权激励计划的议案》。公告显示，出席会议的股东共382人，代表股份218,948,475股，占公司总股份的52.7981%。表决结果显示，同意股份数占出席股东会有效表决权股份总数的95.9021%，反对占3.9976%，弃权占0.1004%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120500040475.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"gpt_icon":0},{"id":"2586347252","title":"*ST双成：销售模式为招商与市场推广结合","url":"https://stock-news.laohu8.com/highlight/detail?id=2586347252","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586347252?lang=zh_cn&edition=full","pubTime":"2025-11-26 20:48","pubTimestamp":1764161310,"startTime":"0","endTime":"0","summary":"证券之星消息，*ST双成11月25日在投资者关系平台上答复投资者关心的问题。*ST双成回复：尊敬的投资者您好，公司销售模式主要是招商和市场推广相结合的模式，公司在各地区派驻商务经理，产品以地区或医院为单位进行招商，由专业市场推广公司负责市场调研，学术培训，产品宣传，临床指导，各地商业公司负责药品配送，公司销售人员包括公司商务经理及销售内勤等人员。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112600035628.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"gpt_icon":0},{"id":"2584992387","title":"异动快报：*ST双成（002693）11月19日13点3分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2584992387","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584992387?lang=zh_cn&edition=full","pubTime":"2025-11-19 13:05","pubTimestamp":1763528727,"startTime":"0","endTime":"0","summary":"证券之星11月19日盘中消息，13点3分*ST双成（002693）触及跌停板。目前价格8.05，下跌4.85%。其所属行业化学制药目前下跌。领涨股为山河药辅。该股为半导体，阿尔茨海默病，化学原料药概念热股。11月18日的资金流向数据方面，主力资金净流入2858.27万元，占总成交额12.55%，游资资金净流出1253.06万元，占总成交额5.5%，散户资金净流出1605.21万元，占总成交额7.05%。近5日资金流向一览见下表：*ST双成主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111900017972.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"gpt_icon":0},{"id":"2584953437","title":"*ST双成（002693）披露终止实施2025年限制性股票与股票期权激励计划，11月18日股价上涨4.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584953437","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584953437?lang=zh_cn&edition=full","pubTime":"2025-11-18 22:13","pubTimestamp":1763475201,"startTime":"0","endTime":"0","summary":"截至2025年11月18日收盘，*ST双成报收于8.46元，较前一交易日上涨4.96%，最新总市值为35.08亿元。近日，海南双成药业股份有限公司发布公告称，公司于2025年11月18日召开第五届董事会第二十四次会议，审议通过了关于终止实施2025年限制性股票与股票期权激励计划的议案。截至公告日，激励计划尚未实际授予，不影响公司股权结构和财务状况。公司承诺自公告之日起3个月内不再审议股权激励计划。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111800039713.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"gpt_icon":0},{"id":"2584609085","title":"异动快报：*ST双成（002693）11月18日9点35分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2584609085","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584609085?lang=zh_cn&edition=full","pubTime":"2025-11-18 09:40","pubTimestamp":1763430049,"startTime":"0","endTime":"0","summary":"证券之星11月18日盘中消息，9点35分*ST双成触及涨停板。目前价格8.35，上涨3.6%。其所属行业化学制药目前上涨。领涨股为海南海药。该股为海南概念，阿尔茨海默病，化学原料药概念热股，当日海南概念概念上涨1.83%，阿尔茨海默病概念上涨0.52%，化学原料药概念上涨0.32%。11月17日的资金流向数据方面，主力资金净流出1049.13万元，占总成交额16.97%，游资资金净流入282.78万元，占总成交额4.58%，散户资金净流入766.34万元，占总成交额12.4%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111800008027.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"gpt_icon":0},{"id":"2581888486","title":"*ST双成：企业所得税已享受15%税率","url":"https://stock-news.laohu8.com/highlight/detail?id=2581888486","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581888486?lang=zh_cn&edition=full","pubTime":"2025-11-07 20:51","pubTimestamp":1762519915,"startTime":"0","endTime":"0","summary":"证券之星消息，*ST双成11月06日在投资者关系平台上答复投资者关心的问题。*ST双成回复：尊敬的投资者您好，感谢关注，关于海南自由贸易港政策，其中“对注册在海南自贸港并实质性运营的鼓励类产业企业，减按15%的税率征收企业所得税”，我司是高新技术企业，企业所得税已享受15%的税率。公司一直密切关注并深入研究海南自由贸易港的相关政策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110700036575.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"gpt_icon":0},{"id":"2579136911","title":"*ST双成(002693)9月30日股东户数4.42万户，较上期减少19.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579136911","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579136911?lang=zh_cn&edition=full","pubTime":"2025-10-30 17:40","pubTimestamp":1761817207,"startTime":"0","endTime":"0","summary":"证券之星消息，近日*ST双成披露，截至2025年9月30日公司股东户数为4.42万户，较6月30日减少1.07万户，减幅为19.43%。户均持股数量由上期的7565.0股增加至9389.0股，户均持股市值为7.23万元。在化学制药行业个股中，*ST双成股东户数高于行业平均水平，截至9月30日，化学制药行业平均股东户数为3.43万户。从股价来看，2025年6月30日至2025年9月30日，*ST双成区间涨幅为4.62%，在此期间股东户数减少1.07万户，减幅为19.43%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000033959.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"gpt_icon":0},{"id":"2579319745","title":"*ST双成：公司没有该专利","url":"https://stock-news.laohu8.com/highlight/detail?id=2579319745","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579319745?lang=zh_cn&edition=full","pubTime":"2025-10-30 17:00","pubTimestamp":1761814834,"startTime":"0","endTime":"0","summary":"证券之星消息，*ST双成(002693)10月30日在投资者关系平台上答复投资者关心的问题。投资者提问：专利名称：一种无菌兰瑞肽原料药的制备方法，是否为贵公司专利？*ST双成回复：尊敬的投资者您好，感谢您的关注。公司没有该专利。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000030959.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"gpt_icon":0},{"id":"2579975201","title":"*ST双成：不存在提前泄露3季度业绩的情况","url":"https://stock-news.laohu8.com/highlight/detail?id=2579975201","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579975201?lang=zh_cn&edition=full","pubTime":"2025-10-30 16:57","pubTimestamp":1761814633,"startTime":"0","endTime":"0","summary":"证券之星消息，*ST双成(002693)10月30日在投资者关系平台上答复投资者关心的问题。投资者提问：贵公司3季度业绩是否已经泄露？二级市场如此剧烈波动*ST双成回复：尊敬的投资者您好，二级市场股价波动受多重因素共同影响，包括宏观经济环境、资本市场整体走势、行业周期特征、公司基本面以及市场情绪等。公司严格执行《信息披露管理办法》及《内幕信息知情人登记、管理和保密制度》等相关规定，始终高度重视信息保密工作，不存在提前泄露3季度业绩的情况。感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000030863.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"gpt_icon":0},{"id":"2579132670","title":"股市必读：*ST双成（002693）10月29日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2579132670","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579132670?lang=zh_cn&edition=full","pubTime":"2025-10-30 05:31","pubTimestamp":1761773475,"startTime":"0","endTime":"0","summary":"截至2025年10月29日收盘，*ST双成报收于7.77元，下跌0.51%，换手率3.55%，成交量14.6万手，成交额1.13亿元。董秘最新回复投资者： 今年的财务指标已经符合退市标准,为何还要搞股权激励董秘： 尊敬的投资者您好，感谢您对公司的关注。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000004154.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002693"],"gpt_icon":0},{"id":"2579109187","title":"图解*ST双成三季报：第三季度单季净利润同比增长176.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579109187","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579109187?lang=zh_cn&edition=full","pubTime":"2025-10-30 03:01","pubTimestamp":1761764486,"startTime":"0","endTime":"0","summary":"证券之星消息，*ST双成2025年三季报显示，前三季度公司主营收入1.69亿元，同比上升33.04%；归母净利润-252.35万元，同比上升93.33%；扣非净利润-586.62万元，同比上升85.31%；其中2025年第三季度，公司单季度主营收入8478.18万元，同比上升164.39%；单季度归母净利润1594.31万元，同比上升176.31%；单季度扣非净利润1514.96万元，同比上升168.35%；负债率49.32%，投资收益7.06万元，财务费用716.6万元，毛利率56.71%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000003013.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693"],"gpt_icon":0},{"id":"2579998038","title":"股市必读：*ST双成（002693）10月28日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2579998038","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579998038?lang=zh_cn&edition=full","pubTime":"2025-10-29 02:19","pubTimestamp":1761675584,"startTime":"0","endTime":"0","summary":"董秘最新回复投资者： 贵公司3季度业绩数据是否能够做到真实有效？董秘： 尊敬的投资者您好，公司第五届董事会的任期为2025年1月9日至2026年1月9日。董秘： 尊敬的投资者您好，公司三季报的预约披露时间为2025年10月30日，具体业绩情况请以公司届时披露的定期报告为准，感谢您的关注。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900002783.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"gpt_icon":0},{"id":"2578940933","title":"*ST双成：公司各位高管均正常履职","url":"https://stock-news.laohu8.com/highlight/detail?id=2578940933","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578940933?lang=zh_cn&edition=full","pubTime":"2025-10-28 16:51","pubTimestamp":1761641471,"startTime":"0","endTime":"0","summary":"证券之星消息，*ST双成(002693)10月28日在投资者关系平台上答复投资者关心的问题。投资者提问：贵公司各位高管是否正常履职在岗？*ST双成回复：尊敬的投资者您好，公司各位高管均正常履职。感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102800029349.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"gpt_icon":0},{"id":"2577533315","title":"股市必读：*ST双成（002693）10月23日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2577533315","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577533315?lang=zh_cn&edition=full","pubTime":"2025-10-24 03:29","pubTimestamp":1761247748,"startTime":"0","endTime":"0","summary":"截至2025年10月23日收盘，*ST双成报收于7.66元，上涨1.46%，换手率1.3%，成交量5.32万手，成交额4035.18万元。董秘最新回复投资者： 贵公司股票如果单单因为业绩营收不达标而被强制退市，于晓风女士是否会主动辞职？当日关注点来自交易信息汇总：10月23日主力资金净流入642.68万元，显示主力对*ST双成的短期关注度提升。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102400003638.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"gpt_icon":0},{"id":"2577801386","title":"股市必读：*ST双成（002693）10月21日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2577801386","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577801386?lang=zh_cn&edition=full","pubTime":"2025-10-22 03:36","pubTimestamp":1761075372,"startTime":"0","endTime":"0","summary":"截至2025年10月21日收盘，*ST双成报收于7.51元，上涨0.4%，换手率0.97%，成交量4.0万手，成交额2993.16万元。董秘最新回复投资者： 请问现在股东人数是多少？董秘： 尊敬的投资者您好，请致电0898-68592978，谢谢！当日关注点来自交易信息汇总：10月21日主力资金净流出340.99万元，显示主力对*ST双成持谨慎态度。来自交易信息汇总：游资资金净流入210.81万元，表明短线资金存在一定参与意愿。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102200003718.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"gpt_icon":0},{"id":"2577878075","title":"*ST双成：未接到实控人及大股东减持计划通知","url":"https://stock-news.laohu8.com/highlight/detail?id=2577878075","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577878075?lang=zh_cn&edition=full","pubTime":"2025-10-21 20:51","pubTimestamp":1761051098,"startTime":"0","endTime":"0","summary":"证券之星消息，*ST双成(002693)10月20日在投资者关系平台上答复投资者关心的问题。投资者提问：贵公司实控人及大股东，是否有减持计划？*ST双成回复：尊敬的投资者您好，截至目前，公司未接到实控人及大股东关于减持股份计划的通知。感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102100034616.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"gpt_icon":0},{"id":"2576831609","title":"*ST双成：股票收盘价连续二十个交易日低于1元将被终止上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2576831609","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576831609?lang=zh_cn&edition=full","pubTime":"2025-10-20 16:42","pubTimestamp":1760949726,"startTime":"0","endTime":"0","summary":"证券之星消息，*ST双成10月20日在投资者关系平台上答复投资者关心的问题。*ST双成回复：尊敬的投资者您好，根据《深圳证券交易所股票上市规则》第9.2.1条“上市公司出现下列情形之一的，本所终止其股票上市交易：（四）在本所仅发行A股股票或者仅发行B股股票的公司，通过本所交易系统连续二十个交易日的股票收盘价均低于1元”。公司股票2025年10月20日收盘价为7.48元，未触及上述相关法规。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102000020198.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"gpt_icon":0},{"id":"2576831933","title":"*ST双成：于晓风女士为公司董事会秘书","url":"https://stock-news.laohu8.com/highlight/detail?id=2576831933","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576831933?lang=zh_cn&edition=full","pubTime":"2025-10-20 16:39","pubTimestamp":1760949552,"startTime":"0","endTime":"0","summary":"证券之星消息，*ST双成(002693)10月20日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵公司董秘是否为于晓风？*ST双成回复：尊敬的投资者您好，于晓风女士为公司董事会秘书，感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102000020135.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002693","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765654404130,"stockEarnings":[{"period":"1week","weight":-0.0072},{"period":"1month","weight":-0.14},{"period":"3month","weight":-0.1179},{"period":"6month","weight":-0.0802},{"period":"1year","weight":-0.696},{"period":"ytd","weight":-0.6247}],"compareEarnings":[{"period":"1week","weight":-0.0034},{"period":"1month","weight":-0.0277},{"period":"3month","weight":0.0048},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.1236},{"period":"ytd","weight":0.1604}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"海南双成药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"44166人(较上一季度减少19.43%)","perCapita":"9305股","listingDate":"2012-08-08","address":"海南省海口市秀英区兴国路16号","registeredCapital":"41468万元","survey":" 海南双成药业股份有限公司的主营业务是药品注射剂、固体制剂、原料药的研发、生产、销售。公司的主要产品是注射用生长抑素、注射用比伐芦定、依替巴肽注射液、醋酸奥曲肽注射液、注射用紫杉醇(白蛋白结合型)。公司曾荣获国家知识产权示范企业、优势企业奖励。","listedPrice":20},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"*ST双成(002693)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供*ST双成(002693)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"*ST双成,002693,*ST双成股票,*ST双成股票老虎,*ST双成股票老虎国际,*ST双成行情,*ST双成股票行情,*ST双成股价,*ST双成股市,*ST双成股票价格,*ST双成股票交易,*ST双成股票购买,*ST双成股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"*ST双成(002693)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供*ST双成(002693)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}